Innovex International, Capex To Revenue vs Total Revenue

INVX Stock

13.97 0.16 1.16%

Innovex International, financial indicator trend analysis is infinitely more than just investigating Innovex International, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innovex International, is a good investment. Please check the relationship between Innovex International, Capex To Revenue and its Total Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovex International,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Innovex Stock please use our How to Invest in Innovex International, guide.

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innovex International, Capex To Revenue account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Innovex International,'s Capex To Revenue and Total Revenue is -0.08. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Innovex International,, assuming nothing else is changed. The correlation between historical values of Innovex International,'s Capex To Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Innovex International, are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Capex To Revenue i.e., Innovex International,'s Capex To Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.08

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Most indicators from Innovex International,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innovex International, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovex International,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Innovex Stock please use our How to Invest in Innovex International, guide.Tax Provision is expected to decline to about 7.4 M this year. Selling General Administrative is expected to decline to about 64.7 M this year

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	4.0M	4.6M	4.9M
Depreciation And Amortization	17.7M	18.5M	30.5M	27.1M

Interest Expense Depreciation And Amortization

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Good Will
Total Assets		-0.78	0.58	0.58	1.0	0.97	-0.3	-0.93	0.96	0.07	0.92	0.95	0.88	0.02	0.93	0.82	0.53	-0.74	0.87	0.84	-0.45	0.12	1.0	0.61	0.93	0.27
Short Long Term Debt Total	-0.78		-0.42	-0.4	-0.8	-0.84	0.01	0.8	-0.79	-0.02	-0.77	-0.74	-0.63	0.15	-0.78	-0.62	-0.36	0.94	-0.61	-0.63	0.42	0.19	-0.77	-0.21	-0.84	-0.09
Other Current Liab	0.58	-0.42		0.94	0.52	0.62	-0.13	-0.32	0.38	0.13	0.29	0.39	0.4	0.13	0.29	0.69	0.74	-0.48	0.83	0.6	0.13	0.66	0.62	0.55	0.62	0.42
Total Current Liabilities	0.58	-0.4	0.94		0.52	0.6	-0.06	-0.34	0.4	0.35	0.31	0.45	0.43	0.11	0.32	0.71	0.72	-0.41	0.76	0.49	0.13	0.76	0.61	0.47	0.64	0.38
Total Stockholder Equity	1.0	-0.8	0.52	0.52		0.97	-0.3	-0.95	0.98	0.03	0.94	0.95	0.88	0.03	0.95	0.79	0.5	-0.77	0.84	0.84	-0.49	0.03	0.99	0.6	0.93	0.26
Property Plant And Equipment Net	0.97	-0.84	0.62	0.6	0.97		-0.19	-0.9	0.93	0.02	0.89	0.93	0.9	0.0	0.89	0.78	0.55	-0.79	0.86	0.81	-0.42	0.11	0.96	0.53	0.96	0.28
Current Deferred Revenue	-0.3	0.01	-0.13	-0.06	-0.3	-0.19		0.19	-0.33	-0.09	-0.19	-0.26	-0.13	-0.12	-0.19	-0.36	-0.11	0.09	-0.32	-0.2	0.31	0.04	-0.3	-0.67	-0.09	-0.19
Net Debt	-0.93	0.8	-0.32	-0.34	-0.95	-0.9	0.19		-0.95	0.1	-0.99	-0.93	-0.88	-0.15	-0.99	-0.62	-0.48	0.77	-0.67	-0.71	0.51	0.18	-0.91	-0.48	-0.9	-0.17
Retained Earnings	0.96	-0.79	0.38	0.4	0.98	0.93	-0.33	-0.95		0.06	0.94	0.95	0.87	0.03	0.95	0.76	0.4	-0.75	0.74	0.81	-0.64	-0.09	0.95	0.53	0.88	0.18
Accounts Payable	0.07	-0.02	0.13	0.35	0.03	0.02	-0.09	0.1	0.06		-0.11	0.1	-0.06	-0.38	-0.08	0.42	-0.19	0.15	0.0	-0.1	0.02	0.49	0.07	-0.21	0.04	-0.27
Cash	0.92	-0.77	0.29	0.31	0.94	0.89	-0.19	-0.99	0.94	-0.11		0.93	0.89	0.09	1.0	0.6	0.42	-0.73	0.67	0.71	-0.51	-0.17	0.9	0.47	0.87	0.16
Non Current Assets Total	0.95	-0.74	0.39	0.45	0.95	0.93	-0.26	-0.93	0.95	0.1	0.93		0.92	-0.01	0.94	0.68	0.4	-0.67	0.73	0.69	-0.49	0.03	0.91	0.52	0.89	0.2
Non Currrent Assets Other	0.88	-0.63	0.4	0.43	0.88	0.9	-0.13	-0.88	0.87	-0.06	0.89	0.92		0.08	0.89	0.6	0.41	-0.55	0.69	0.66	-0.46	0.09	0.85	0.44	0.85	0.21
Other Assets	0.02	0.15	0.13	0.11	0.03	0.0	-0.12	-0.15	0.03	-0.38	0.09	-0.01	0.08		0.07	-0.09	0.67	-0.02	0.05	0.09	-0.03	-0.1	0.04	0.36	0.13	0.29
Cash And Short Term Investments	0.93	-0.78	0.29	0.32	0.95	0.89	-0.19	-0.99	0.95	-0.08	1.0	0.94	0.89	0.07		0.61	0.41	-0.73	0.66	0.7	-0.52	-0.17	0.9	0.46	0.88	0.15
Net Receivables	0.82	-0.62	0.69	0.71	0.79	0.78	-0.36	-0.62	0.76	0.42	0.6	0.68	0.6	-0.09	0.61		0.43	-0.52	0.76	0.75	-0.31	0.4	0.85	0.47	0.77	0.07
Common Stock Shares Outstanding	0.53	-0.36	0.74	0.72	0.5	0.55	-0.11	-0.48	0.4	-0.19	0.42	0.4	0.41	0.67	0.41	0.43		-0.5	0.66	0.51	0.07	0.28	0.55	0.64	0.65	0.53
Non Current Liabilities Total	-0.74	0.94	-0.48	-0.41	-0.77	-0.79	0.09	0.77	-0.75	0.15	-0.73	-0.67	-0.55	-0.02	-0.73	-0.52	-0.5		-0.67	-0.68	0.44	0.24	-0.75	-0.4	-0.77	-0.29
Inventory	0.87	-0.61	0.83	0.76	0.84	0.86	-0.32	-0.67	0.74	0.0	0.67	0.73	0.69	0.05	0.66	0.76	0.66	-0.67		0.84	-0.21	0.37	0.89	0.76	0.79	0.56
Other Current Assets	0.84	-0.63	0.6	0.49	0.84	0.81	-0.2	-0.71	0.81	-0.1	0.71	0.69	0.66	0.09	0.7	0.75	0.51	-0.68	0.84		-0.49	0.06	0.87	0.6	0.74	0.31
Other Stockholder Equity	-0.45	0.42	0.13	0.13	-0.49	-0.42	0.31	0.51	-0.64	0.02	-0.51	-0.49	-0.46	-0.03	-0.52	-0.31	0.07	0.44	-0.21	-0.49		0.44	-0.43	-0.22	-0.28	-0.06
Total Liab	0.12	0.19	0.66	0.76	0.03	0.11	0.04	0.18	-0.09	0.49	-0.17	0.03	0.09	-0.1	-0.17	0.4	0.28	0.24	0.37	0.06	0.44		0.14	0.18	0.13	0.17
Total Current Assets	1.0	-0.77	0.62	0.61	0.99	0.96	-0.3	-0.91	0.95	0.07	0.9	0.91	0.85	0.04	0.9	0.85	0.55	-0.75	0.89	0.87	-0.43	0.14		0.63	0.93	0.28
Short Term Debt	0.61	-0.21	0.55	0.47	0.6	0.53	-0.67	-0.48	0.53	-0.21	0.47	0.52	0.44	0.36	0.46	0.47	0.64	-0.4	0.76	0.6	-0.22	0.18	0.63		0.46	0.63
Common Stock	0.93	-0.84	0.62	0.64	0.93	0.96	-0.09	-0.9	0.88	0.04	0.87	0.89	0.85	0.13	0.88	0.77	0.65	-0.77	0.79	0.74	-0.28	0.13	0.93	0.46		0.21
Good Will	0.27	-0.09	0.42	0.38	0.26	0.28	-0.19	-0.17	0.18	-0.27	0.16	0.2	0.21	0.29	0.15	0.07	0.53	-0.29	0.56	0.31	-0.06	0.17	0.28	0.63	0.21

Click cells to compare fundamentals

High Positive Relationship

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Stockholder Equity
Retained Earnings	+ 0.98	Total Stockholder Equity
Property Plant And Equipment Net	+ 0.97	Total Assets

High Negative Relationship

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Retained Earnings	- 0.95	Net Debt
Net Debt	- 0.95	Total Stockholder Equity
Non Current Assets Total	- 0.93	Net Debt
Net Debt	- 0.93	Total Assets

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.2B	284.9M	436.3M	1.0B	1.1B
Other Current Liab	42.2M	35.5M	18.4M	23.4M	42.1M	45.8M
Total Current Liabilities	96.9M	85.5M	69.6M	85.0M	117.7M	87.0M
Total Stockholder Equity	1.1B	1.0B	180.6M	251.3M	881.3M	918.2M
Property Plant And Equipment Net	263.6M	242.0M	37.5M	69.9M	235.1M	237.2M
Current Deferred Revenue	6.9M	11.3M	9.7M	8.0M	7.6M	11.1M
Net Debt	(397.4M)	(344.7M)	25.5M	73.0M	(189.1M)	(198.5M)
Retained Earnings	1.2B	1.1B	8.7M	72.0M	950.7M	858.4M
Accounts Payable	46.3M	37.4M	38.3M	41.7M	65.7M	40.8M
Cash	398.9M	346.0M	9.7M	8.4M	191.4M	265.3M
Non Current Assets Total	326.1M	288.0M	92.0M	153.9M	308.5M	273.5M
Non Currrent Assets Other	13.5M	10.9M	(9.5M)	3.5M	5.8M	8.7M
Cash And Short Term Investments	398.9M	346.0M	9.7M	8.4M	217.3M	266.7M
Net Receivables	248.2M	256.5M	82.7M	126.2M	284.0M	216.8M
Common Stock Shares Outstanding	36.2M	35.3M	35.3M	34.2M	34.5M	30.4M
Liabilities And Stockholders Equity	1.2B	1.2B	//window.location = "/error404.html"; Updating Transaction... Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions Feedback Blog Made with optimal in San Francisco 2024 Macroaxis LLC COMMON DESTINATIONS My Portfolios Thematic Proposal Market Map Investment Tools Equity Filter ETFs Funds Companies Insiders Buy or Sell Advice Correlations Patterns Technical Analysis Risk-Return Landscape Investing Ideas Portfolio Center Financial Advisers Economic Indicators MAIN CATEGORIES Portfolio Optimization Equity Research Economic Indicators Watchlist Tools AI Investment Finder FinTech Suite Market Snapshot Latest Stories Investing Sectors AI Portfolio Architect Financial Widgets COMPANY Macroaxis Sign-In Home About Us Contact Us Quick Product Tour FAQs Privacy Policy Terms Of Use Plan & Pricing

Innovex Capex To Revenue vs Total Revenue Analysis

Capex To Revenue vs Total Revenue

Capex To Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Capex To Revenue

Total Revenue

Innovex International, fundamental ratios Correlations

Innovex International, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innovex International, fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY